Home » OrbusNeich’s Bio-Engineered Stent Shows Favorable Safety Profile, Clinical Outcomes
OrbusNeich’s Bio-Engineered Stent Shows Favorable Safety Profile, Clinical Outcomes
OrbusNeich announced that six-month follow-up clinical trial data demonstrate the excellent safety profile and efficacy of the company’s Genous Bio-engineered R stent in combination with a paclitaxel-coated balloon for the treatment of de novo coronary artery disease.
WTHR
WTHR
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May